Similar articles

• Comparative effectiveness and comparative costs.

  Liu L, Rettenmaier AJ, Saving TR. Liu L, et al. Oncology (Williston Park). 2010 May;24(6):537. Oncology (Williston Park). 2010. PMID: 20568595 No abstract available.
• Quality-adjusted life-years, comparative effectiveness in cancer care, and measuring outcomes in the underserved.

  Kilbridge KL. Kilbridge KL. Oncology (Williston Park). 2010 May;24(6):530-6. Oncology (Williston Park). 2010. PMID: 20568594
• [Economic evaluation of targeted cancer therapy].

  Ikeda S. Ikeda S. Gan To Kagaku Ryoho. 2013 Aug;40(8):967-70. Gan To Kagaku Ryoho. 2013. PMID: 23986036 Review. Japanese.
• Taking quality of life into account in health economic analyses.

  Weeks J. Weeks J. J Natl Cancer Inst Monogr. 1996;(20):23-7. J Natl Cancer Inst Monogr. 1996. PMID: 8750463
• Cancer outcomes research.

  Lipscomb J, Donaldson MS, Arora NK, Brown ML, Clauser SB, Potosky AL, Reeve BB, Rowland JH, Snyder CF, Taplin SH. Lipscomb J, et al. J Natl Cancer Inst Monogr. 2004;(33):178-97. doi: 10.1093/jncimonographs/lgh039. J Natl Cancer Inst Monogr. 2004. PMID: 15504928 Review. No abstract available.